1st - Use the lab to clear infill sampling for Konks PFS - done
2nd - Clear the backlog of 2012 regional samples - partially done , but still ongoing I believe.
3rd - Prep samples from new [2012/13] targets as they arrive, get regular assays to test if heading in the right direction, evaluate results , see if they are on trend, change direction or continue in right direction. This is part of a more conservative and cost effective approach, which will see slower , but more meaningful results when they do arrive. And this isn't a new approach , but rather a return to the old approach, now that the labs have settled down and they have the prep facility. Once again they are being guided by results not assumptions.
I have no problem waiting a little longer for better quality results. What I do have a problem with , is when they state in a quarterly report that results are explected in mid-feb , and they miss that target. Better to say nothing at all .
Underpromise , overdeliver.
AMX Price at posting:
26.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)